Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common stock, par value $ 0.000001 per share
-
Shares outstanding
-
6.51M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
3.34M
-
Shares change
-
-439K
-
Total reported value, excl. options
-
$63.7M
-
Value change
-
-$66.1M
-
Number of buys
-
24
-
Number of sells
-
-21
-
Price
-
$19.09
Significant Holders of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) as of Q4 2024
56 filings reported holding TIL - Instil Bio, Inc. - Common stock, par value $ 0.000001 per share as of Q4 2024.
Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.34M shares
of 6.51M outstanding shares and own 51.33% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (585K shares), CPMG Inc (411K shares), BML Capital Management, LLC (400K shares), Boxer Capital Management, LLC (356K shares), Siren, L.L.C. (192K shares), VANGUARD GROUP INC (151K shares), SUPERSTRING CAPITAL MANAGEMENT LP (148K shares), RENAISSANCE TECHNOLOGIES LLC (134K shares), GOLDMAN SACHS GROUP INC (127K shares), and ORBIMED ADVISORS LLC (117K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.